VE
Vext Science, Inc.
VEXT.CN · CNQ
$0.23 +0.00% (+$0.00)
1M -15.09%
Market Cap $39.9M
P/E Ratio -
Div. Yield -
ROE 25.02%
Bulios Fair Price
$0.12
47.8% downside
Current Price
$0.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VEXT.CN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap P/S 0.79x
P/B 0.74x
P/FCF 11.53x
Growth
65 /100
Stable Book val. growth 8.40%
Rev. growth 13.86%
FCF growth N/A
Profitability
20 /100
Weak Net margin 28.84%
Op. margin 18.26%
FCF margin 6.88%
Quality
5 /100
Poor ROE 25.02%
ROA 12.42%
Asset turnover 0.43x
Debt
31 /100
High Current ratio 0.97x
Int. coverage -2.15x
Net debt/EBITDA 4.83x
Stability
38 /100
Moderate Rev. volatility 25.72%
EPS volatility 242.87%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VEXT.CN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Eric J. Offenberger
Employees
173
Headquarters
Phoenix
Upcoming events
19 NOV
Earnings
Upcoming earnings report